Neurovascular interventions encompass a range of procedures and techniques aimed at diagnosing and treating disorders affecting the blood vessels of the brain and spinal cord. These interventions are performed by specialized healthcare providers, often neurosurgeons or interventional neuroradiologists, and are crucial for managing conditions such as strokes, aneurysms, and arteriovenous malformations (AVMs). One common neurovascular intervention is endovascular therapy, which involves accessing the blood vessels of the brain or spine through minimally invasive techniques, such as catheterization, and delivering treatments directly to the site of the vascular abnormality. This may include techniques such as angioplasty to open narrowed or blocked vessels, embolization to block abnormal blood flow in AVMs or aneurysms, or thrombectomy to remove blood clots in acute stroke. Another important neurovascular intervention is surgical revascularization, which involves creating new blood flow pathways to bypass blocked or narrowed arteries in the brain. This may be done using techniques such as bypass surgery, where a healthy blood vessel from another part of the body is grafted to the affected area of the brain to restore blood flow. Neurovascular interventions also play a crucial role in the management of acute stroke, where rapid intervention is essential to minimize brain damage and improve outcomes. This may involve administering clot-busting medications such as tissue plasminogen activator (tPA) or performing mechanical thrombectomy to remove the clot causing the stroke. In addition to treating acute conditions, neurovascular interventions are also used for preventive purposes, such as treating asymptomatic aneurysms or arteriovenous malformations to prevent rupture or hemorrhage.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States